Meyka AI API is live for developers.Start building.
Advertisement
Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc. (APGE) Stock Overview

Explore Apogee Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

APGE●NASDAQ
HealthcareBiotechnology
$82.91
$0.10(0.12%)
U.S. Market is Open · 14:34
Advertisement

Apogee Therapeutics, Inc. (APGE)

Meyka AI Score

Z

Key Financials

Market Cap5.3B
P/E Ratio-21.41
EPS (TTM)$-4.33
ROE-0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$73.65
3 Months$76.72
1 Year Target$78.55

APGE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Apogee Therapeutics, Inc. (APGE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $78.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21.41 and a market capitalization of 5.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.40%
5-Day Change
1.19%
1-Month Change
2.37%
3-Month Change
13.42%
6-Month Change
13.73%
Year-to-Date (YTD) Change
12.61%
1-Year Change
111.81%
3-Year Change
300.38%
5-Year Change
300.38%
All-Time (Max) Change
300.38%

Contact Information

https://www.apogeetherapeutics.com
650-394-5230
221 Crescent Street, Waltham, MA, 02453

Company Facts

196 Employees
IPO DateJul 14, 2023
CountryUS
Actively Trading

Frequently Asked Questions